Lymphangiographic evaluation of patients with clinical lepromatous leprosy on clofazimine.

Abstract

Pedal edema as a possible adverse effect of clofazimine therapy in leprosy was first reported in 1990. Raasch, et al. reported their lymphangiographic findings on ten patients who had clinical lepromatous leprosy in 1969. None of these patients had been on clofazimine therapy. Our study, therefore, was designed to assess the changes that might be seen in the lymphatic system of patients treated with clofazimine for the management of leprosy. Our findings are compared with those of Raasch and his colleagues.

• Authors: S T Oommen, M V Natu, M K Mahajan, R S Kadyan
• Journal: International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association (Int J Lepr Other Mycobact Dis) Vol. 62 Issue 1 Pg. 32-6 (Mar 1994) ISSN: 0148-916X [Print] United States
• PMID: 8189086 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)

Chemical References

• Clofazimine

Topics

• Adolescent
• Adult
• Clofazimine (adverse effects)
• Humans
• Leprosy, Lepromatous (drug therapy)
• Lymphedema (chemically induced, diagnostic imaging)
• Lymphography
• Middle Aged